Comorbidity and beyond: pre-transplant clinical assessment
- 1 September 2005
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 36 (6) , 473-474
- https://doi.org/10.1038/sj.bmt.1705042
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Comorbidity indices in hematopoietic stem cell transplantation: a new report cardBone Marrow Transplantation, 2005
- Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?Leukemia, 2004
- Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donorsBlood, 2004
- Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbiditiesBlood, 2004
- Effect of comorbidities on allogeneic hematopoietic stem cell transplant outcomes in AML/MDS patients in first complete remissionTransplantation and Cellular Therapy, 2004
- Geriatric oncologyCritical Reviews in Oncology/Hematology, 2003
- Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factorBone Marrow Transplantation, 2003
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- Comorbidity and functional status are independent in older cancer patients.Journal of Clinical Oncology, 1998
- Cancer and comorbidity in older patients: A descriptive profileAnnals of Epidemiology, 1996